A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
|Articles|February 27, 2018
- February 2018 Immunization Supplement
- Volume 84
- Issue 2
Guide to Adult Immunizations
Advertisement
View the PDF
References
1. American Academy of Pediatrics. Recommended Childhood and Adolescent Immunizaiton Schedules: United States, 2018. http://pediatrics.aappublications.org/content/early/2018/02/02/ peds.2018-0083. Accessed February 6, 2018.
2. Centers for Disease Control and Prevention. www.cdc.gov/vaccines/schedules/hcp/child-adolescent.html#changes. Accessed February 6, 2018.
Articles in this issue
over 8 years ago
Herpes Zoster: Talking Points on the New Vaccine for Patientsover 8 years ago
Improving Adherence With Immunization SchedulesAdvertisement
Related to this article
Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
Authors of a pharmacist-directed transitions-of-care study discuss what drives pneumococcal vaccine hesitancy and how pharmacists can build systematic vaccine screening into inpatient workflows.
Investigational anti-amyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
3
Ramantamig's 93.6% ORR and Outpatient CRS Control
4
Engineered Stem Cell Therapy Reverses New-Onset T1D in Mice by Reprogramming T Cells
5